Publikationen W. Löscher

Gericke, B., Römermann, K., Noack, A., Noack, S., Kronenberg, J., Blasig, I. E., & Löscher, W. (2020). A face-to-face comparison of claudin-5 transduced human brain endothelial (hCMEC/D3) cells with porcine brain endothelial cells as blood-brain barrier models for drug transport studies. Fluids and Barriers of the CNS, 17: 53. https://doi.org/10.1186/s12987-020-00212-5
Details anzeigen
Henke, C., Töllner, K., van Dijk, R. M., Miljanovic, N., Cordes, T., Twele, F., Bröer, S., Ziesak, V., Rohde, M., Hauck, S. M., Vogel, C., Welzel, L., Schumann, T., Willmes, D. M., Kurzbach, A., El-Agroudy, N. N., Bornstein, S. R., Schneider, S. A., Jordan, J., … Löscher, W. (2020). Disruption of the sodium-dependent citrate transporter SLC13A5 in mice causes alterations in brain citrate levels and neuronal network excitability in the hippocampus. Neurobiology of Disease, 143: 105018. https://doi.org/10.1016/j.nbd.2020.105018
Details anzeigen
Klein, P., Friedman, A., Hameed, M. Q., Kaminski, R. M., Bar-Klein, G., Klitgaard, H., Koepp, M., Jozwiak, S., Prince, D. A., Rotenberg, A., Twyman, R., Vezzani, A., Wong, M., & Löscher, W. (2020). Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy? Epilepsia: The Journal of the International League Against Epilepsy, 61(3), 359–386. https://doi.org/10.1111/epi.16450
Details anzeigen
Löscher, W. (2020). The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments. Neuropharmacology, 167: 107605. https://doi.org/10.1016/j.neuropharm.2019.04.011
Details anzeigen
Löscher, W., & Friedman, A. (2020). Structural, molecular, and functional alterations of the blood-brain barrier during epileptogenesis and epilepsy: a cause, consequence, or both? International Journal of Molecular Sciences, 21(2: 591). https://doi.org/10.3390/ijms21020591
Details anzeigen
Löscher, W., & Gericke, B. (2020). Novel intrinsic mechanisms of active drug extrusion at the blood-brain barrier: Potential targets for enhancing drug delivery to the brain? Pharmaceutics, 12(10: 966). https://doi.org/10.3390/pharmaceutics12100966
Details anzeigen
Löscher, W., & Klein, P. (2020). The feast and famine: Epilepsy treatment and treatment gaps in early 21st century. Neuropharmacology, 170: 108055. https://doi.org/10.1016/j.neuropharm.2020.108055
Details anzeigen
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020). Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options. Pharmacological Reviews, 72(3), 606–638. https://doi.org/10.1124/pr.120.019539
Details anzeigen
Moschny, N. K. (2020). Epigenetics in Psychiatry – Characterization of the Immune System and Its Methylome in Depressed Patients Receiving Electroconvulsive Therapy. https://elib.tiho-hannover.de/receive/tiho_mods_00001677
Details anzeigen
Müller, F. E. (2020). Serotonergic Signaling and Impact of small GTPases in Astrocytes. https://elib.tiho-hannover.de/receive/tiho_mods_00001256
Details anzeigen